CSOFT International

CSOFT International is a translation, localization, and global communication services provider that helps international businesses reach out to customers around the world.

Empire Boston – Thank You for Attending our Event!

Thank you to all for making Tuesday a special evening! CSOFT’s sponsored V.I.P. Social at the elegant Empire Restaurant Boston was a large success. We welcomed guests from around the world within the medical industry. The evening’s cuisine was paired with smooth Jazz and great conversation. All of it was made possible by our wonderful […]

Boston VIP Social

On September 24th, from 6:30 PM – 8:30 PM, CSOFT will be sponsoring and co-organizing a V.I.P Social with AdvaMed at the elegant Empire Restaurant Boston. This event will be one you don’t want to miss. Not only will you make valuable connections with others in the medical technology industry, but you will have the […]

2019 MedTech Conference in Boston

On September 23-25th, CSOFT will be attending the Medtech Conference in Boston along with 3,000 other attendees to network and share insight with medical technology industry leaders. Attendees will have the opportunity to witness more than 300 speakers discuss topics pertinent to today’s medical technology industry such as the increasing use of artificial intelligence, regulations […]

Translating China: Succeeding in China’s Translation Industry

At 11:00 EDT on July 18, 2018 Joshua Hughman, Director of Business Development, Europe, who was previously the Director of Business development for our Global Communications department based in China at CSOFT International will be presenting a Webinar partnered with GALA (Globalization and Localization Association) about how he has found success in the Chinese translation […]

Dragon Boats: A Long History of Connecting Cultures

CSOFT’s 15th Annual Summit officially takes off on June 6th. This is our second summit at our Boston office – we tested the waters in the Fall of 2018, and this time we’re really pushing the boat out. Twice, in fact.

CSOFT’s 15th Annual Summit: Dragons, Tea, and Boats, Oh My!

Our 15th Annual Summit: Global Leaders Networking event will focus on a variety of life science industry topics. Leading executives & experts from sectors such as MedTech, pharma, and diagnostics will be hosting afternoon sessions at the Boston Public Library’s ornate Courtyard Tea Room, sharing their expertise on how to expand life science products and services internationally.

E-Learning and m-Learning Translations In The Technology Age

With the increased access to technology and the availability of resources, e-learning has become available internationally and is only rising. Platforms can advance their presence in new markets through translations and localization.

Rare Disease Day 2019

With over 350 million patients currently diagnosed with a rare disease worldwide, what makes a rare disease ‘rare’? With the growing need for medical translations in research and patents, CSOFT bridges the gap of global healthcare.

Unique Challenges Translating to South East Asian Languages

Languages of South East Asia and the Middle East in particular have a reputation for being significantly more difficult to translate due to substantial differences from other languages in terms of text, vocabulary and grammar.

FDA Approves First Treatment of the Rare Disease aTTP

The FDA has approved the first treatment for the rare disease acquired Thrombotic Thrombocytopenic Purpura or aTTP for short. This rare disease occurs in less than .001% of the population and before had no cure.

Spring Festival Message from Shunee Yee: Sharing food, enjoying company

No matter what country you’re from, language you speak, or religion you believe in, enjoying delicious food together is an unchanging nature of mankind – allowing people to connect and appreciate the love of life by sharing stories over a good meal.

FDA Approves The First Generic Inhaler of Advair Diskus

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.